Related Experiment Video
Updated: Apr 30, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Current and emerging therapies for Addison's disease.
Catherine Napier1, Simon H S Pearce
1Institute of Genetic Medicine, Newcastle University, and Endocrine Unit, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
New therapies for Addison's disease, including modified-release hydrocortisone and continuous infusion, aim to better mimic natural cortisol rhythms. These advancements offer hope for improved patient outcomes and quality of life.
Area of Science:
- Endocrinology
- Internal Medicine
Background:
- Addison's disease, or primary adrenal insufficiency, requires lifelong hormone replacement therapy.
- Current standard treatment involves oral hydrocortisone and fludrocortisone, which do not fully replicate physiological cortisol patterns.
Purpose of the Study:
- To review current Addison's disease therapies.
- To highlight recent therapeutic innovations and their potential impact.
Main Methods:
- Literature review of current and emerging treatments for Addison's disease.
- Analysis of new modalities focusing on cortisol rhythm simulation and disease modification.
Main Results:
- Novel treatments include modified-release hydrocortisone and continuous subcutaneous hydrocortisone infusion.
- These new methods offer potential for improved physiological cortisol level management.
- Emerging research explores adrenocorticotropic hormone (ACTH) stimulation and immunomodulation to preserve residual adrenal function.
Conclusions:
- Recent therapeutic developments represent significant advancements after decades of limited innovation in Addison's disease management.
- These novel approaches promise enhanced patient well-being and quality of life.
Related Concept Videos
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Cushing Syndrome I: Introduction
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Heart Failure VI: Adjunct Therapies
Drug Therapy
Antianxiety Medications
Cushing Syndrome II: Pathophysiology

